On December 5, 2019, the Federal Trade Commission announced a $4.1 million settlement against A.S. Research, the marketer of the dietary supplement Synovia. The Commission alleged that ASR mislead consumers by purporting Synovia could dramatically reduce or cure chronic joint pain, stiffness and swelling caused by arthritis, carpal tunnel syndrome, tennis elbow and muscular atrophy.
Continue Reading